Marex Group director granted 2,070 share awards

Ing Sarah reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Ing Sarah reported acquisition or exercise transactions in this Form 4 filing.

Marex Group plc director Ing Sarah reported a grant of 2,070 ordinary shares in the form of restricted share awards. The awards were granted at a price of 0.0000 per share and represent a contingent right to receive one ordinary share per award upon vesting and settlement.

Following this grant, Ing Sarah holds 10,895 ordinary shares directly and 535 ordinary shares indirectly through a spouse. The filing reflects a compensation-related share award rather than an open-market purchase or sale.

Insider Trade Summary

Grant/Award: 2,070 shares

Grant/Award 2 txns

Insider Ing Sarah

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	2,070	$0.00	$0.00
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Ordinary Shares — 10,895 shares (Direct); Ordinary Shares — 535 shares (Indirect, By spouse)

Footnotes (1)

1. F1. The number of ordinary shares reported herein includes 2,070 shares underlying restricted share awards granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.

Key Figures

Restricted share awards granted: 2,070 shares Direct holdings after grant: 10,895 shares Indirect holdings by spouse: 535 shares +1 more

4 metrics

Restricted share awards granted 2,070 shares Grant of ordinary shares as restricted share awards

Direct holdings after grant 10,895 shares Ordinary shares held directly by Ing Sarah following transaction

Indirect holdings by spouse 535 shares Ordinary shares reported as held indirectly through spouse

Grant price per share 0.0000 per share Reported price for 2,070 restricted share awards

Key Terms

restricted share awards, contingent right, ordinary shares

3 terms

restricted share awards financial

"includes 2,070 shares underlying restricted share awards granted to the Reporting Person"

Restricted share awards are grants of company stock given to employees or executives that cannot be sold or transferred until certain conditions—typically staying with the company for a set time or meeting performance goals—are met. They matter to investors because they can dilute existing shares when they vest, signal management’s incentives and confidence, and affect a company’s future earnings per share much like a delayed paycheck that becomes available only after you meet agreed milestones.

contingent right financial

"Each award represents a contingent right to receive one (1) ordinary share"

ordinary shares financial

"The number of ordinary shares reported herein includes 2,070 shares underlying restricted share awards"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Marex Group (MRX) report for Ing Sarah?

Marex Group reported that director Ing Sarah received 2,070 ordinary shares as restricted share awards. These awards are part of compensation and give a contingent right to one ordinary share per award upon vesting and settlement.

How many Marex Group (MRX) shares does Ing Sarah hold after the Form 4?

After the reported grant, Ing Sarah holds 10,895 Marex Group ordinary shares directly. The filing also shows 535 ordinary shares held indirectly through a spouse, giving a combined reported position of 11,430 ordinary shares.

What are the terms of the 2,070 restricted share awards at Marex Group (MRX)?

Each of the 2,070 restricted share awards represents a contingent right to receive one Marex Group ordinary share. The shares are delivered upon vesting and settlement of the applicable award, with no purchase price shown in the filing.

Was the Marex Group (MRX) Form 4 a market purchase or sale by Ing Sarah?

The Form 4 shows a grant or award acquisition, not an open-market trade. Ing Sarah received 2,070 ordinary shares as restricted share awards, which are compensation-related rather than a discretionary market buy or sell.

Does Ing Sarah have indirect ownership of Marex Group (MRX) shares?

Yes. In addition to direct holdings, the Form 4 reports 535 Marex Group ordinary shares held indirectly by a spouse. These indirect holdings are disclosed separately from the 10,895 shares held directly in Ing Sarah’s name.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 04:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ing Sarah

(Last) (First) (Middle)

C/O MAREX GROUP PLC, 155 BISHOPSGATE

(Street)

LONDON UNITED KINGDOM EC2M 3TQ

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Marex Group plc [ MRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/09/2026		A		2,070	A	$0	10,895(1)	D
Ordinary Shares								535	I	By spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The number of ordinary shares reported herein includes 2,070 shares underlying restricted share awards granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.

	/s/ Scott Linsley as Attorney-in-Fact, for Sarah Ing	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)